Anzeige
Mehr »
Login
Mittwoch, 28.09.2022 Börsentäglich über 12.000 News von 675 internationalen Medien
Wo es gerade richtig läuft!? – Wo kann man jetzt Geld verdienen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.08.ONS data reveals significant decrease in COVID-19 antibodies
12.08.Roche's Xofluza issued FDA approval to treat influenza in children aged five years and older
11.08.How the Royal Society's EiR programme can help to drive UK innovation
11.08.BMS and 2seventy bio announce positive results for multiple myeloma treatment
11.08.Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
11.08.Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
11.08.JCVI publishes statement on London polio vaccination strategy
11.08.AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy
10.08.My body. My choice. Are we all talking about the same thing?
10.08.BeiGene announces positive phase 3 trial results for liver cancer treatment
10.08.Sanofi halts recruitment for trials assessing MS treatment
10.08.Merck and Cerevance to research novel targets in Alzheimer's disease
10.08.Michael J Fox Foundation awards Koneksa second research grant
10.08.FDA approves Bot Image's AI software for the detection and diagnosis of prostate cancer
09.08.Strategic commitment
09.08.Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
09.08.AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
09.08.NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
09.08.Bayer's Nubeqa receives FDA approval to treat metastatic prostate cancer
09.08.Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
08.08.Born strategic - Why great strategists are both born and made
08.08.AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
08.08.ONS records a continued fall in UK COVID-19 infections
08.08.ICR research shows how skin cancer cells invade new tissues
08.08.bluebird bio reveals plans to launch two gene therapies